With 45% institutional ownership, BeiGene, Ltd. (NASDAQ:BGNE) is a favorite amongst the big guns

In This Article:

Key Insights

  • Institutions' substantial holdings in BeiGene implies that they have significant influence over the company's share price

  • A total of 6 investors have a majority stake in the company with 50% ownership

  • Insiders have been selling lately

A look at the shareholders of BeiGene, Ltd. (NASDAQ:BGNE) can tell us which group is most powerful. With 45% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.

Let's delve deeper into each type of owner of BeiGene, beginning with the chart below.

See our latest analysis for BeiGene

ownership-breakdown
NasdaqGS:BGNE Ownership Breakdown December 24th 2024

What Does The Institutional Ownership Tell Us About BeiGene?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors have a fair amount of stake in BeiGene. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at BeiGene's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
NasdaqGS:BGNE Earnings and Revenue Growth December 24th 2024

It looks like hedge funds own 17% of BeiGene shares. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Looking at our data, we can see that the largest shareholder is Amgen Inc. with 18% of shares outstanding. For context, the second largest shareholder holds about 9.0% of the shares outstanding, followed by an ownership of 8.1% by the third-largest shareholder. Additionally, the company's CEO John Oyler directly holds 3.5% of the total shares outstanding.

We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.